Takács I, Radványi G, Szegedi G, Matolcsy A, Semsei I
Debreceni Orvostudományi Egyetem, III. Belgyógyászati Klinika, Molekuláris Biológiai Kutató Laboratórium, Debrecen.
Orv Hetil. 1997 May 4;138(18):1129-32.
In most cases of centroblastic/centrocytic follicular lymphomas the bcl-2 proto-oncogene (18q21) is translocated to the immunoglobulin JH region of chromosome 14 (14q32). About three quarters of the translocations are concentrated on the 3' nontranslated, a few hundred basepare-long region of bcl-2, the so called major breakpoint region (mbr), the remaining 20-25% is located about 30 kilobases downstream of bcl-2 coding sequences in the minor cluster region (mcr). The majority of the immunoglobulin breakpoints can be found in JH6-4 genes. The polymerase chain reaction method can detect the translocation already in a very few number of cells (> 10(3)). This very sensitive technique makes it possible to detect the translocation in lymphoid/lymphoma of peripheral blood and bone marrow that are missed by other diagnostic methods. This way one can perform a quick, early diagnosis, examine the result of treatments as well as detect the remissions and the possible relapses right at the beginning. All the advantages of this method contribute to a more successful treatment of follicular lymphoma. This present work describes a polymerase chain reaction technique which is capable of a detection of the t(14;18) translocation in a patient of centroblastic/centrocytic lymphoma, moreover shows how this translocation disappears after 4 week of radiotherapy of the patient.
在大多数中心母细胞性/中心细胞性滤泡性淋巴瘤病例中,bcl - 2原癌基因(18q21)易位至14号染色体(14q32)的免疫球蛋白JH区域。约四分之三的易位集中在bcl - 2的3'非翻译区,即几百个碱基对长的所谓主要断裂点区域(mbr),其余20% - 25%位于bcl - 2编码序列下游约30千碱基处的次要簇区域(mcr)。大多数免疫球蛋白断裂点可在JH6 - 4基因中发现。聚合酶链反应方法在极少数量的细胞(>10³)中就能检测到这种易位。这种非常灵敏的技术使得在外周血和骨髓的淋巴样组织/淋巴瘤中检测到易位成为可能,而其他诊断方法可能会遗漏这些易位。通过这种方式,可以进行快速、早期诊断,检查治疗结果以及在一开始就检测到缓解情况和可能的复发。该方法的所有优点有助于更成功地治疗滤泡性淋巴瘤。本研究描述了一种聚合酶链反应技术,该技术能够检测中心母细胞性/中心细胞性淋巴瘤患者中的t(14;18)易位,此外还展示了该患者放疗4周后这种易位是如何消失的。